Peer-reviewedCC BYJournal of mass spectrometry and advances in the clinical lab
Iatrogenic Cushing’s Syndrome from a Joint Health Supplement: Identification of Undeclared Pharmaceuticals by HRMS
- 1Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
- 2Division of Endocrinology and Metabolism, Department of Medicine, University of California San Francisco, CA, USA.
Related
- Gynecomastia in iatrogenic Cushing syndrome.
- BRASH syndrome in acute coronavirus disease 2019 myocarditis and acute kidney injury: The importance of early recognition of an iatrogenic spiral.
- Iatrogenic Cushing Syndrome With Glucocorticoid-Induced Adrenal Insufficiency Following Prolonged Topical Clobetasol Use in an Adolescent
- Iatrogenic Cushing Syndrome With Hypothalamic-Pituitary-Adrenal Axis Suppression in a Two-Month-Old Infant Following Unsupervised Topical Corticosteroid Use: A Case Report
- Undeclared Pharmacologically Active Ingredients in Over-the-Counter Skin Products
BibTeX
@article{lusk2026iatrogenic,
title = {{Iatrogenic Cushing’s Syndrome from a Joint Health Supplement: Identification of Undeclared Pharmaceuticals by HRMS}},
author = {Hannah J Lusk and Sarah Kim and Kara L Lynch},
journal = {Journal of mass spectrometry and advances in the clinical lab},
year = {2026},
month = aug,
doi = {10.21627/2xkas668},
url = {https://europepmc.org/article/PMC/PMC13753983},
note = {CC BY},
}
RIS
TY - JOUR
TI - Iatrogenic Cushing’s Syndrome from a Joint Health Supplement: Identification of Undeclared Pharmaceuticals by HRMS
AU - Hannah J Lusk
AU - Sarah Kim
AU - Kara L Lynch
PY - 2026
DA - 2026/08/21
JO - Journal of mass spectrometry and advances in the clinical lab
DO - 10.21627/2xkas668
UR - https://europepmc.org/article/PMC/PMC13753983
SN - 2667-1468
SN - 2667-145X
ER -